Literature DB >> 9672897

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders.

W C Drevets1, D Ongür, J L Price.   

Abstract

The prefrontal cortex (PFC) ventral to the genu of the corpus callosum has been implicated in the modulation of visceral responses to stressful and emotionally provocative stimuli, based upon analysis of lesion effects involving this area in humans and experimental animals. In a recent magnetic resonance imaging (MRI) study of familial mood disorders, we demonstrated that the mean grey matter volume of this cortex is abnormally reduced in subjects with major depressive disorder (MDD) and bipolar disorder, irrespective of their treatment status or current mood state. Moreover, in preliminary histopathological assessments of subgenual PFC tissue taken post mortem from subjects with MDD and bipolar disorder we obtained results suggesting that this decrement in grey matter volume is associated with a reduction in glia without an equivalent loss of neurons. The potential functional significance of these neuroimaging and microscopic abnormalities is discussed with respect to evidence that subgenual PFC dysfunction may disturb stress-related autonomic and neuroendocrine responses and reward-related mesolimbic dopamine function. These data may thus hold important implications for the development of neural models of mood disorders that can account for the abnormal hedonic, motivational, neuroendocrine, and autonomic manifestations evident in these idiopathic conditions.

Entities:  

Mesh:

Year:  1998        PMID: 9672897     DOI: 10.1038/sj.mp.4000370

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  87 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

3.  Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7.

Authors:  Zhenglin Gu; Wenhua Liu; Jing Wei; Zhen Yan
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

4.  Affective and cognitive modulation of performance monitoring: behavioral and ERP evidence.

Authors:  Emiliana R Simon-Thomas; Robert T Knight
Journal:  Cogn Affect Behav Neurosci       Date:  2005-09       Impact factor: 3.282

5.  Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder.

Authors:  Xiujun Sun; Jun-Feng Wang; Michael Tseng; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

6.  Managing bipolar disorder from urgent situations to maintenance therapy.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 7.  Divergent plasticity of prefrontal cortex networks.

Authors:  Bita Moghaddam; Houman Homayoun
Journal:  Neuropsychopharmacology       Date:  2007-10-03       Impact factor: 7.853

Review 8.  Volumetric brain imaging studies in the elderly with mood disorders.

Authors:  John L Beyer
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

9.  Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume, and sulcal depth.

Authors:  Alex Fornito; Stephen J Wood; Sarah Whittle; Jack Fuller; Chris Adamson; Michael M Saling; Dennis Velakoulis; Christos Pantelis; Murat Yücel
Journal:  Hum Brain Mapp       Date:  2008-02       Impact factor: 5.038

Review 10.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.